Reproductive factors and ovarian cancer risk in African-American women

Annals of Epidemiology

Volumn 26, Issue 9, 2016, Pages 654-662

  Moorman, Patricia G ^a   Alberg, Anthony J ^b   Bandera, Elisa V ^c   Barnholtz Sloan, Jill ^d   Bondy, Melissa ^e   Cote, Michele L ^f   Funkhouser, Ellen ^g   Peters, Edward S ^h   Schwartz, Ann G ^f   Terry, Paul ⁱ   Crankshaw, Sydnee ^a   Wang, Frances ^a   Schildkraut, Joellen M ^j  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f KARMANOS CANCER INSTITUTE   (United States)

^g University of Alabama at Birmingham   (United States)

^h Department of Oral and Craniofacial Biology   (United States)

ⁱ UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF VIRGINIA   (United States)

more..

Author keywords

African Americans; Breastfeeding; Case control study; Oral contraceptives; Ovarian cancer; Parity; Pregnancy

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST FEEDING; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PARITY; PREGNANCY; PREMENOPAUSE; PRIORITY JOURNAL; REPRODUCTION; RISK FACTOR; AGE; CAUCASIAN; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; ETHNOLOGY; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; ODDS RATIO; OVARY TUMOR; PATHOPHYSIOLOGY; PREDICTIVE VALUE; REPRODUCTIVE HISTORY; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; UNITED STATES; YOUNG ADULT;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; BREAST FEEDING; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CONTRACEPTIVES, ORAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; ODDS RATIO; OVARIAN NEOPLASMS; PARITY; PREDICTIVE VALUE OF TESTS; REPRODUCTIVE HISTORY; RISK ASSESSMENT; UNITED STATES; YOUNG ADULT;

EID: 84991594091     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2016.07.004     Document Type: Article

References (35)

1. [1] Howlader, N., N, A., Krapcho, M., Garshell, J., Miller, D., Altekruse, S.F., et al. (eds.) SEER Cancer Statistics Review, 1975-2012, 2015, Institute NC, Bethesda, MD.
2. [2] Permuth-Wey, J., S, T., Epidemiology of ovarian cancer. M, V., (eds.) Methods of Molecular Biology, Cancer Epidemiology, Vol. 472, 2009, Humana Press, Totowa, NJ, 413–437.
3. [3] Moorman, P.G., Calingaert, B., Palmieri, R.T., Iversen, E.S., Bentley, R.C., Halabi, S., et al. Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women. Am J Epidemiol 167:9 (2008), 1059–1069.
4. [4] Tung, K.H., Wilkens, L.R., Wu, A.H., McDuffie, K., Nomura, A.M., Kolonel, L.N., et al. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis. Am J Epidemiol 161:4 (2005), 321–329.
5. [5] Whiteman, D.C., Siskind, V., Purdie, D.M., Green, A.C., Timing of pregnancy and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 12:1 (2003), 42–46.
6. [6] Titus-Ernstoff, L., Perez, K., Cramer, D.W., Harlow, B.L., Baron, J.A., Greenberg, E.R., Menstrual and reproductive factors in relation to ovarian cancer risk. Br J Cancer 84:5 (2001), 714–721.
7. [7] Kuper, H., Cramer, D.W., Titus-Ernstoff, L., Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status?. Cancer Causes Control 13:5 (2002), 455–463.
8. [8] Cooper, G.S., Schildkraut, J.M., Whittemore, A.S., Marchbanks, P.A., Pregnancy recency and risk of ovarian cancer. Cancer Causes Control 10:5 (1999), 397–402.
9. [9] Beehler, G.P., Sekhon, M., Baker, J.A., et al. Risk of ovarian cancer associated with BMI varies by menopausal status. J Nutr 136:11 (2006), 2881–2886.
10. [10] Albrektsen, G., Heuch, I., Kvale, G., Reproductive factors and incidence of epithelial ovarian cancer: a Norwegian prospective study. Cancer Causes Control 7:4 (1996), 421–427.
11. [11] Fairfield, K.M., Willett, W.C., Rosner, B.A., Manson, J.E., Speizer, F.E., Hankinson, S.E., Obesity, weight gain, and ovarian cancer. Obstet Gynecol 100:2 (2002), 288–296.
12. [12] Gwinn, M.L., Lee, N.C., Rhodes, P.H., Layde, P.M., Rubin, G.L., Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol 43:6 (1990), 559–568.
13. [13] Martin, J.A., Hamilton, B.E., Osterman, M.J., Curtin, S.C., Matthews, T.J., Births: final data for 2012. Natl Vital Stat Rep 62:9 (2013), 1–68.
14. [14] Centers for Disease C, Prevention. Progress in increasing breastfeeding and reducing racial/ethnic differences—United States, 2000-2008 births. MMWR Morb Mortal Wkly Rep 62:5 (2013), 77–80.
15. [15] Daniels, K., Mosher, W.D., Contraceptive methods women have ever used: United States, 1982-2010. Natl Health Stat Report(62), 2013, 1–15.
16. [16] Moorman, P.G., Palmieri, R.T., Akushevich, L., Berchuck, A., Schildkraut, J.M., Ovarian cancer risk factors in African-American and white women. Am J Epidemiol 170 (2009), 598–606.
17. [17] Ness, R.B., Grisso, J.A., Klapper, J., Vergona, R., Racial differences in ovarian cancer risk. J Natl Med Assoc 92:4 (2000), 176–182.
18. [18] John, E.M., Whittemore, A.S., Harris, R., Itnyre, J., Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case-control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group. J Natl Cancer Inst 85:2 (1993), 142–147.
19. [19] Wu, A.H., Pearce, C.L., Tseng, C.C., Pike, M.C., African Americans and Hispanics remain at lower risk of ovarian cancer than non-Hispanic whites after considering nongenetic risk factors and oophorectomy rates. Cancer Epidemiol Biomarkers Prev 24:7 (2015), 1094–1100.
20. [20] Schildkraut, J.M., Alberg, A.J., Bandera, E.V., Barnholtz-Sloan, J., Bondy, M., Cote, M.L., et al. A multi-center population-based case-control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES). BMC Cancer, 14, 2014, 688.
21. [21] McKnight, B., Cook, L.S., Weiss, N.S., Logistic regression analysis for more than one characteristic of exposure. Am J Epidemiol 149:11 (1999), 984–992.
22. [22] Fathalla, M.F., Incessant ovulation—a factor in ovarian neoplasia?. Lancet, 2(7716), 1971, 163.
23. [23] Ness, R.B., Cottreau, C., Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 91:17 (1999), 1459–1467.
24. [24] Fleming, J.S., Beaugie, C.R., Haviv, I., Chenevix-Trench, G., Tan, O.L., Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol 247:1-2 (2006), 4–21.
25. [25] Siskind, V., Green, A., Bain, C., Purdie, D., Beyond ovulation: oral contraceptives and epithelial ovarian cancer. Epidemiology 11:2 (2000), 106–110.
26. [26] Risch, H.A., Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90:23 (1998), 1774–1786.
27. [27] Lukanova, A., Kaaks, R., Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev 14:1 (2005), 98–107.
28. [28] Kurman, R.J., Shih Ie, M., The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34:3 (2010), 433–443.
29. [29] Li, J., Fadare, O., Xiang, L., Kong, B., Zheng, W., Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis. J Hematol Oncol, 5, 2012, 8.
30. [30] Fathalla, M.F., Incessant ovulation and ovarian cancer—a hypothesis re-visited. Facts Views Vis Obgyn 5:4 (2013), 292–297.
31. [31] Nguyen, H., Syed, V., Progesterone inhibits growth and induces apoptosis in cancer cells through modulation of reactive oxygen species. Gynecol Endocrinol 27:10 (2011), 830–836.
32. [32] Collaborative Group on Epidemiological Studies of Ovarian C, Beral, V., Doll, R., Hermon, C., Peto, R., Reeves, G., Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 371:9609 (2008), 303–314.
33. [33] Yang, H.P., Trabert, B., Murphy, M.A., Sherman, M.E., Sampson, J.N., Brinton, L.A., et al. Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study. Int J Cancer 131:4 (2012), 938–948.
34. [34] Tung, K.H., Goodman, M.T., Wu, A.H., McDuffie, K., Wilkens, L.R., Kolonel, L.N., et al. Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study. Am J Epidemiol 158:7 (2003), 629–638.
35. [35] Modugno, F., Ness, R.B., Wheeler, J.E., Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness. Ann Epidemiol 11:8 (2001), 568–574.